However, inhibiting Gln-dependent transaminases including GOT2, GPT-1, GPT-2, and PSAT-1 had essentially no impact on proliferation of cells no matter under high or low glucose conditions, suggesting that liver cancer cells maintained survival under different nutritional conditions through the metabolic flexibility of their Gln-related enzymes (63). The gene discussed is GPT; the disease is liver cancer.